v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Cash flows from operating activities:      
Net loss $ (27,292) $ (20,293) $ (15,062)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 15,908 13,924 11,594
Stock compensation expense 13,489 6,177 1,447
Change in fair value of warrants liability 0 3,307 2,058
Amortization of debt discount 389 445 798
Loss on extinguishment of debt 0 1,073 0
Cost of Phreesia hardware purchased by customers 762 741 585
Deferred contract acquisition cost amortization 2,025 1,977 1,640
Non-cash operating lease expense 1,766 0 0
Deferred tax asset (65) (775) 0
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (6,619) (5,905) (3,765)
Prepaid expenses and other assets (1,600) (312) (576)
Deferred contract acquisition costs (1,652) (2,097) (2,500)
Accounts payable (3,821) (30) 2,367
Accrued expenses and other liabilities 6,004 3,681 (2,317)
Lease liability (1,786) 0 0
Deferred revenue 5,382 (1,087) 1,601
Net cash provided by (used in) operating activities 2,890 826 (2,130)
Cash flows used in investing activities:      
Acquisitions, net of cash acquired (6,510) 0 (1,190)
Capitalized internal-use software (7,334) (5,305) (5,109)
Purchases of property and equipment (11,241) (7,015) (4,724)
Net cash used in investing activities (25,085) (12,320) (11,023)
Cash flows from financing activities:      
Net proceeds after discounts and offering expenses 174,800 130,781 0
Payment of preferred stock dividends 0 (14,955) 0
Proceeds from issuance of common stock upon exercise of stock options 4,385 1,809 361
Tax withholdings on stock compensation awards (4,965) 0 0
Payment of offering costs (290) (6,217) (195)
Proceeds from revolving line of credit 0 9,876 14,800
Payments of revolving line of credit (20,663) (17,676) (7,000)
Proceeds from term loan 0 20,000 0
Repayment of term loan and loan payable 0 (21,042) (1,167)
Insurance financing arrangement (2,009) 0 0
Principal portion of finance lease payments (2,630) (1,898) (2,470)
Principal payments on financing arrangements (1,691) 0 0
Debt extinguishment costs 0 (300) 0
Debt issuance costs (69) (112) (136)
Loan facility fee payment (225) 0
Net cash provided by financing activities 150,661 100,266 4,193
Net increase (decrease) in cash and cash equivalents 128,466 88,772 (8,960)
Cash and cash equivalents—beginning of year 90,315 1,543 10,503
Cash and cash equivalents—end of year 218,781 90,315 1,543
Supplemental information:      
Right-of-use assets recorded in exchange for operating lease liabilities [1] 4,359 0 0
Property and equipment acquisitions through finance leases 8,885 2,047 4,425
Capitalized software acquired through financings 174 0 0
Purchase of property and equipment and capitalized software included in accounts payable 3,359 1,253 0
Cashless transfer of term loan and related accrued fees into increase in debt balance 20,257 0 0
Cashless transfer of lender fees through increase in debt balance 406 0 0
Deferred issuance costs included in accounts payable and accrued expenses 0 0 344
Issuance of warrants related to debt 0 833 0
Receivables for cash in-transit on stock option exercises 915 0 0
Cashless exercise of common stock warrants 3,060 3,530 0
Shares issued in connection with acquisition 0 0 162
Cash paid for:      
Interest 1,465 2,310 2,799
Income taxes $ 64 $ 0 $ 0
[1] Includes $2,741 initial right of use asset recorded upon adoption of ASC 842.